Embryotoxic effects adjacent and opposite to the early regressing bovine corpus luteum.
Early luteal regression in cattle has an embryotoxic effect that is not overcome by replacement with progesterone, but is prevented by removal of the regressing CL. Two experiments were designed to test the null hypothesis that the luteal component of the embryotoxic effect is delivered by a systemic pathway. Beef heifers and cows (n = 39) received two good quality embryos, one placed into each uterine horn on Day 6 or 7 of the estrous cycle. Treated animals (n = 20) received 15 mg of PGF2alpha three times per day from Day 7 (n = 11; Experiment 1) or 5 (n = 9; Experiment 2) through 8; controls (n = 19) received saline. Progestogen replacement therapy (12 mg flurogestone acetate daily, s.c.) was provided from Day 6 (Experiment 1) or 4 (Experiment 2) until ultrasonographic diagnosis of embryo survival on Day 35 after estrus. The effects of treatment, location of the embryo and location by treatment interaction on embryo survival were tested by Chi square. In Experiment 1, there was no significant difference in embryo survival rate between PGF2alpha-treated and control recipients. In Experiment 2, only 6 of 18 embryos survived to Day 35 when transferred to animals treated with PGF2alpha compared to 12 of 18 in control animals (P< 0.05). The survival of embryos did not differ with location (adjacent or opposite to the regressing CL) or location by treatment interaction. Thus no evidence was obtained to support a local effect of the regressing CL. The embryo mortality associated with luteolytic doses of PGF2alpha in cows receiving replacement therapy with progestogen probably involves compounds that either act systemically or are transported via the uterine lumen to the uterine horn contralateral to the regressing CL.
Hernandez-Fonseca
H J
HJ
Division of Animal and Veterinary Sciences, West Virginia University, Morgantown 26506, USA.
Sayre
B L
BL
Butcher
R L
RL
Inskeep
E K
EK
D000818:Animals; D002417:Cattle / Q000196:embryology*; D003338:Corpus Luteum / Q000502:physiology*; D020964:Embryo Loss / Q000517:prevention & control*; D004624:Embryo Transfer / Q000662:veterinary; D004971:Estrus; D005260:Female; D011374:Progesterone / Q000627:therapeutic use
D011374:Progesterone